Korro Bio (KRRO) FCF Margin (2019 - 2025)
Korro Bio's FCF Margin history spans 6 years, with the latest figure at 1376.63% for Q4 2025.
- For the quarter ending Q4 2025, FCF Margin fell 98266.0% year-over-year to 1376.63%, compared with a TTM value of 1237.16% through Dec 2025, up 219640.0%, and an annual FY2025 reading of 1237.16%, up 219640.0% over the prior year.
- FCF Margin for Q4 2025 was 1376.63% at Korro Bio, up from 1592.11% in the prior quarter.
- The five-year high for FCF Margin was 7465.49% in Q1 2023, with the low at 1592.11% in Q3 2025.
- Average FCF Margin over 4 years is 131.21%, with a median of 774.9% recorded in 2025.
- Year-over-year, FCF Margin plummeted -4565bps in 2021 and then crashed -98266bps in 2025.
- Tracing KRRO's FCF Margin over 4 years: stood at 176.72% in 2021, then surged by 4324bps to 7465.49% in 2023, then plummeted by -105bps to 393.97% in 2024, then crashed by -249bps to 1376.63% in 2025.
- Per Business Quant, the three most recent readings for KRRO's FCF Margin are 1376.63% (Q4 2025), 1592.11% (Q3 2025), and 1326.58% (Q2 2025).